Effects of Therapeutic Hypothermia Combined with Other Neuroprotective Strategies on Ischemic Stroke: Review of Evidence

Ischemic stroke is a major cause of death and disability globally, and its incidence is increasing. The only treatment approved by the US Food and Drug Administration for acute ischemic stroke is thrombolytic treatment with recombinant tissue plasminogen activator. As an alternative, therapeutic hyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zheng, Zhang, Linlei, Ding, Yuchuan, Han, Zhao, Ji, Xunming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988605/
https://www.ncbi.nlm.nih.gov/pubmed/29896438
http://dx.doi.org/10.14336/AD.2017.0628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988605/
https://www.ncbi.nlm.nih.gov/pubmed/29896438
http://dx.doi.org/10.14336/AD.2017.0628

Ejemplares similares